CVT-4325: a potent fatty acid oxidation inhibitor with favorable oral bioavailability

E Elzein, P Ibrahim, DO Koltun, K Rehder…

Index: Bioorganic and Medicinal Chemistry Letters, , vol. 14, # 24 p. 6017 - 6021

Full Text: HTML

Citation Number: 23

Abstract

... Bioorganic & Medicinal Chemistry Letters. Volume 14, Issue 24, 20 December 2004, Pages 6017–6021. Cover image Cover image. ... a Department of Bioorganic Chemistry, CV Therapeutics, Inc., 3172 Porter Dr., Palo Alto, CA 94304, USA; ...

Related Articles:

Piperazine-Based CCR5 Antagonists as HIV-1 Inhibitors. II. Discovery of 1-[(2, 4-Dimethyl-3-pyridinyl) carbonyl]-4-methyl-4-[3 (S)-methyl-4-[1 (S)-[4-(trifluoro-methyl) …

[Journal of Medicinal Chemistry, , vol. 44, # 21 p. 3343 - 3346]

More Articles...